The Fibronectin III-1 Domain Activates a PI3-Kinase/Akt Signaling Pathway Leading to αbβ5 Integrin Activation and TRAIL Resistance in Human Lung Cancer Cells

被引：0
|
作者：
Cho, Christina [1 ]
McKeown-Longo, Paula [1 ]
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
lb82
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Angiotensin II/Angiotensin II Type I Receptor (AT1R) Signaling Promotes MCF-7 Breast Cancer Cells Survival via PI3-Kinase/Akt Pathway
    Zhao, Yanbin
    Chen, Xuesong
    Cai, Li
    Yang, Yanmei
    Sui, Guangjie
    Fu, Songbin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 225 (01) : 168 - 173
  • [42] Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway
    Nguyen, DM
    Chen, GA
    Reddy, R
    Tsai, W
    Schrump, WD
    Cole, G
    Schrump, DS
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (02): : 365 - 375
  • [43] Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-κB-dependent pathway
    Fong, Yi-Chin
    Liu, Shan-Chi
    Huang, Chun-Yin
    Li, Te-Mao
    Hsu, Sheng-Feng
    Kao, Shung-Te
    Tsai, Fuu-Jen
    Chen, Wen-Chi
    Chen, Chih-Yi
    Tang, Chih-Hsin
    LUNG CANCER, 2009, 64 (03) : 263 - 270
  • [44] ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
    Hodkinson, P. S.
    Elliott, T.
    Wong, W. S.
    Rintoul, R. C.
    Mackinnon, A. C.
    Haslett, C.
    Sethi, T.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (10): : 1776 - 1788
  • [45] ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
    P S Hodkinson
    T Elliott
    W S Wong
    R C Rintoul
    A C Mackinnon
    C Haslett
    T Sethi
    Cell Death & Differentiation, 2006, 13 : 1776 - 1788
  • [46] Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NFκB Pathway in Human Non-small Cell Lung Cancer (vol 17, pg 1839, 2011)
    Song, Libing
    Xiong, Huaping
    Li, Jun
    Liao, Wenting
    Wang, Lan
    Wu, Jueheng
    Li, Mengfeng
    CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1740 - 1740
  • [47] Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells
    Aksamitiene, Edita
    Achanta, Sirisha
    Kolch, Walter
    Kholodenko, Boris N.
    Hoek, Jan B.
    Kiyatkin, Anatoly
    CELLULAR SIGNALLING, 2011, 23 (11) : 1794 - 1805
  • [48] TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5
    Jin, Xiaoying
    Wang, Dandan
    Lei, Mengxia
    Guo, Yan
    Cui, Yuqing
    Chen, Fengzhi
    Sun, Weiling
    Chen, Xuesong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [49] TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5
    Xiaoying Jin
    Dandan Wang
    Mengxia Lei
    Yan Guo
    Yuqing Cui
    Fengzhi Chen
    Weiling Sun
    Xuesong Chen
    Journal of Translational Medicine, 20
  • [50] Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation of IGF-1R/PI3K/Akt signaling pathway
    Zhang, Jingtao
    Wen, Guilan
    Sun, Longhua
    Yuan, Wenxin
    Wang, Ran
    Zeng, Qinghua
    Zhang, Guangyi
    Yu, Bentong
    ONCOLOGY REPORTS, 2018, 40 (05) : 2926 - 2934
12345